Altimmune (ALT) | 2016-2017 | 19,899,900% |
AquaBounty Technologies (AQB) | 2016-2017 | 48,788.89% |
Eterna Therapeutics (ERNA) | 2016-2017 | 2,405.95% |
AIxCrypto (AIXC) | 2016-2017 | 909.2% |
InMed Pharmaceuticals (INM) | 2016-2017 | 749.64% |
Madrigal Pharmaceuticals (MDGL) | 2016-2017 | 694.72% |
Fennec Pharmaceuticals (FENC) | 2016-2017 | 591.03% |
AnaptysBio (ANAB) | 2016-2017 | 529.5% |
Assembly Biosciences (ASMB) | 2016-2017 | 503.33% |
Exelixis (EXEL) | 2016-2017 | 452.73% |
Evotec SE ADR (EVO) | 2016-2017 | 414.61% |
Abeona Therapeutics (ABEO) | 2016-2017 | 381.76% |
Corbus Pharmaceuticals (CRBP) | 2016-2017 | 327.71% |
ProMIS Neurosciences (PMN) | 2016-2017 | 325% |
argenx NV ADR (ARGX) | 2016-2017 | 252.74% |
BeiGene (ONC) | 2016-2017 | 237.31% |
Palvella Therapeutics (PVLA) | 2016-2017 | 231.14% |
Star Equity (STRR) | 2016-2017 | 218.04% |
UroGen Pharma (URGN) | 2016-2017 | 180.2% |
Biocardia (BCDA) | 2016-2017 | 179.76% |
DiaMedica Therapeutics (DMAC) | 2016-2017 | 163.16% |
Cibus Global LLC (CBUS) | 2016-2017 | 131.89% |
Ascendis Pharma A-S (ASND) | 2016-2017 | 121.82% |
Amarin (AMRN) | 2016-2017 | 115.59% |
Vericel Corp Ord (VCEL) | 2016-2017 | 114.57% |
